Reproduction permitted for personal use only. For reprints and reprint permission, contact

Tech and biotech: Asthampolis device cleared for market

Asthmapolis is all fired up after getting clearance from the U.S. Food and Drug Administration in early July to market its high-tech asthma-tracking device.

“It’s very, very exciting. There’s a super-positive, wonderful energy around the office every day,” said Inger Couture, chief regulatory officer.

The young company, established in 2010 based on the work of co-founder David Van Sickle, an asthma epidemiologist and honorary associate fellow at the UW-Madison, already has moved to bigger quarters at 612 W. Main St. from its previous offices at 3 S. Pinckney St.

Couture, hired one year ago, was Asthmapolis’ first employee. Today the company has 13 full-time and part-time staffers and is looking to hire at least six people in the short-term. “We have ads on Twitter and ... everywhere that I can think of,” Couture said.

Read full article>>

-Add Your Comment


Comment Policy: WTN News accepts comments that are on-topic and do not contain advertisements, profanity or personal attacks. Comments represent the views of the individuals who post them and do not necessarily represent the views of WTN Media or our partners, advertisers, or sources. Comments are moderated and are not immediately posted. Your email address will not be posted.

WTN Media cannot accept liability for the content of comments posted here or verify their accuracy. If you believe this comment section is being abused, contact

WTN Media Presents